MarketLens
Sign Up

What Did Legend Biotech's Investor Event Reveal About CARVYKTI

3 months ago
SHARE THIS ON:

What Did Legend Biotech's Investor Event Reveal About CARVYKTI

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 week ago

Enliven Therapeutics: A Clean Active-Site TKI Could Redefine CML Sequencing

Enliven Therapeutics holds $895M cash, funding operations into 2030, after Phase 1 data showed 61% MMR at 80 mg daily for ELVN-001 in chronic myeloid leukemia, supporting earlier-line potential.
News1 months ago

Legend's Pipeline Is Starting To Matter

Legend Biotech swung to $57.7M operating income in Q2, after revenue rose 52% YoY on CARVYKTI's 50% sales growth, driven by earlier-line adoption and global expansion.
Stock News2 months ago

Bristol Myers Squibb Moves Closer to New Multiple Myeloma Treatment

Bristol Myers Squibb's new drug application for mezigdomide combo therapy was accepted by the FDA for relapsed/refractory multiple myeloma, advancing toward a potential new treatment option.

Breaking News

View All →

Top Headlines

View More →
Stock News2 hours ago

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Stock News2 hours ago

Viral AI Dommer Tweet: Engineered Panic?

Stock News3 hours ago

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Stock News4 hours ago

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Stock News6 hours ago

Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today